<rss version="2.0">
  <channel>
    <title>2023年第4期</title>
    <link>https://jhip.gdpu.edu.cn/2023%E5%B9%B4%E7%AC%AC4%E6%9C%9F</link>
    <description><![CDATA[]]></description>
    <item>
      <title>Table of Contents</title>
      <link>https://jhip.gdpu.edu.cn/4nbg4n6jx38yqx6tfrqr0skvwh</link>
      <description><![CDATA[]]></description>
      <pubDate>Fri, 22 Mar 2024 02:10:35 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4nbg4n6jx38yqx6tfrqr0skvwh</guid>
    </item>
    <item>
      <title>Cover page</title>
      <link>https://jhip.gdpu.edu.cn/49v3zbgynp3hm5nhg4hs317rd5</link>
      <description><![CDATA[]]></description>
      <pubDate>Fri, 22 Mar 2024 02:10:00 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/49v3zbgynp3hm5nhg4hs317rd5</guid>
    </item>
    <item>
      <title>Supplementary data: Combining single-cell RNA sequencing data and network pharmacology to explore the mechanism of action of Dayuan Yin in the treatment of acute lung injury</title>
      <link>https://jhip.gdpu.edu.cn/4zadycrynzw0gs32c8mn55fww4</link>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 20 Mar 2024 08:32:39 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4zadycrynzw0gs32c8mn55fww4</guid>
    </item>
    <item>
      <title>Supplementary data: Exploring the therapeutic effects of Zingiberis Rhizoma Preparatum (Pao-Jiang) against DSS-induced ulcerative colitis in mice by metabolomics-guided analysis</title>
      <link>https://jhip.gdpu.edu.cn/4tynzvrh4n9p23228493jt5pxc</link>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 20 Mar 2024 08:30:10 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4tynzvrh4n9p23228493jt5pxc</guid>
    </item>
    <item>
      <title>Combining single-cell RNA sequencing data and network pharmacology to explore the mechanism of action of Dayuan Yin in the treatment of acute lung injury</title>
      <link>https://jhip.gdpu.edu.cn/4wjr1b0w80eg8y35xhqr46sqwt</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">Combining
single-cell RNA sequencing data and network pharmacology to explore the
mechanism of action of Dayuan Yin in the treatment of acute lung injury</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">（结合单细胞<span lang="EN-US">RNA</span>测序数据和网络药理学探讨大元饮治疗急性肺损伤的作用机制）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">摘要<span lang="EN-US">] </span>目的</span></b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt"> 达原饮<span lang="EN-US">(DYY)</span>是一种传统中药<span lang="EN-US">(TCM)</span>配方，对肺部疾病具有良好的作用，但目前还缺少该药治疗急性肺损伤<span lang="EN-US">(ALI)</span>的系统研究。因此，本研究旨在通过单细胞<span lang="EN-US">RNA</span>测序数据和网络药理学的联合分析，探讨<span lang="EN-US">DYY</span>对<span lang="EN-US">ALI</span>分子调控机制的作用。<b>方法</b> 通过单细胞<span lang="EN-US">RNA</span>测序数据集找出差异表达基因，并从中药系统药理学<span lang="EN-US">(TCMSP)</span>数据库中获取<span lang="EN-US">DYY</span>的有效成分和治疗靶点。随后，利用蛋白<span lang="EN-US">-</span>蛋白相互作用<span lang="EN-US">(PPI)</span>网络、基因本体<span lang="EN-US">(GO)</span>和京都基因与基因组百科全书<span lang="EN-US">(KEGG)</span>对关键靶点进行分析。构建了描述化合物、靶点和通路之间相互作用的视觉网络，识别出核心成分。通过分子对接验证活性成分<span lang="EN-US">-</span>核心靶标关系。最后，采用脂多糖诱导的<span lang="EN-US">ALI</span>大鼠模型进行初步实验。<b>结果</b>
单细胞<span lang="EN-US">RNA</span>测序中共鉴定出<span lang="EN-US">5243</span>个<span lang="EN-US">ALI</span>显著差异表达基因，其中<span lang="EN-US">260</span>个基因为<span lang="EN-US">DYY</span>靶基因。然后，在药物与疾病的交叉点鉴定出<span lang="EN-US">81</span>个靶基因。鉴定的核心靶基因包括<span lang="EN-US">PIK3R1</span>、<span lang="EN-US">IL-1</span>β、<span lang="EN-US">IL-6</span>、<span lang="EN-US">ICAM1</span>和<span lang="EN-US">CCL2</span>。<span lang="EN-US">GO</span>分析主要涉及细胞炎症反应、细胞凋亡的双重调控和协同迁移。<span lang="EN-US">KEGG</span>分析显示炎症通路富集。主要活性成分与<span lang="EN-US">IL-1</span>β有良好的联系。<span lang="EN-US">DYY</span>可显著降低<span lang="EN-US">ALI</span>大鼠肺组织中<span lang="EN-US">PI3K</span>、<span lang="EN-US">Akt</span>、<span lang="EN-US">NF<a name="_Hlk157594346">-</a><a name="_Hlk157594332">κ</a>Bp65</span>的磷酸化表达，调节相关炎症细胞的活化。<b>结论</b> 我们成功筛选了<span lang="EN-US">DYY</span>治疗<span lang="EN-US">ALI</span>的潜在有效成分。体内实验初步验证了网络药理学的预测，表明<span lang="EN-US">DYY</span>可以抑制<span lang="EN-US">PI3K/Akt/NF-</span>κВ信号通路，减少细胞因子释放，调节炎症细胞数量，为<span lang="EN-US">ALI</span>治疗提供了一种替代治疗方案。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;color:black;mso-themecolor:
text1"> </span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">单细胞测序；网络药理学；分子对接；达原饮；急性肺损伤<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:18:17 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4wjr1b0w80eg8y35xhqr46sqwt</guid>
    </item>
    <item>
      <title>Exploring the therapeutic effects of Zingiberis Rhizoma Preparatum (Pao-Jiang) against DSS-induced ulcerative colitis in mice by metabolomics-guided analysis</title>
      <link>https://jhip.gdpu.edu.cn/4r5s74am2qe73wb85yeq452050</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">Exploring
the therapeutic effects of Zingiberis Rhizoma Preparatum (Pao-Jiang) against
DSS-induced ulcerative colitis in mice by metabolomics-guided analysis</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">（代谢组学分析导向的炮姜对小鼠溃疡性结肠炎模型治疗作用探究）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">摘要<span lang="EN-US">] </span>目的</span></b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt"> 生姜是药食两用的植物资源。生姜及其干燥品干姜被广泛应用于治疗消化系统疾病的中药方剂中。根据中医理论，干姜的加热炮制品炮姜功效长于温经止血、温中止痛，适用于缓解溃疡性结肠炎的症状。<b>方法</b>
采用药理学评价结合代谢组学分析的方法探究炮姜治疗溃疡性结肠炎的药效及作用机制。<b>结果</b> 干姜及炮姜的水提物和醇提物均能够不同程度上减轻肠道损伤，抑制促炎因子分泌，缓解炎性病理改变。炮姜醇提物显示出更好的效果。靶向和非靶向代谢组学研究显示炮姜醇提物能够调节溃疡性结肠炎诱发的胆汁酸、类二十烷酸及磷脂代谢异常。进一步通过化学成分表征和模拟分子对接发现姜烯酚和姜二酮类成分的含量在炮制后显著提升，其可能通过作用于胆汁酸代谢通路上的关键酶<span lang="EN-US">CYP7A1</span>、<span lang="EN-US">BSEP</span>及<span lang="EN-US">IBABP</span>调节胆汁酸合成及转运，进而发挥抑制炎症药效。<b>结论</b>
本研究的结果拓展了对干姜及炮姜功效的认识，揭示了干姜传统炮制方法的科学内涵。<span lang="EN-US"><o:p></o:p></span></span></p><p>



<b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-ansi-language:EN-US;mso-fareast-language:
ZH-CN;mso-bidi-language:AR-SA">[</span><span style="font-size:14.0pt;
font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;
mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;
font-family:华文中宋;mso-bidi-font-family:&quot;Times New Roman&quot;;color:black;mso-themecolor:
text1;mso-font-kerning:1.0pt;mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;
mso-bidi-language:AR-SA"> </span><span style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">炮姜；溃疡性结肠炎；代谢组学；中药材炮制；胆汁酸代谢</span><br></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:17:27 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4r5s74am2qe73wb85yeq452050</guid>
    </item>
    <item>
      <title>Synthesis, cytotoxicity study of novel bisacridine derivatives and their interaction with c-myc promoter G-quadruplex/i-motif</title>
      <link>https://jhip.gdpu.edu.cn/4b22r263k1sxnrdyax77bez6m7</link>
      <description><![CDATA[<p class="MsoNormal" style="line-height:150%"><span lang="EN-US" style="font-size:
14.0pt;line-height:150%;font-family:华文中宋;color:black;mso-themecolor:text1">Synthesis,
cytotoxicity study of novel bisacridine derivatives and their interaction with <i>c-myc</i> promoter G-quadruplex/i-motif</span><span style="font-size:14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">（</span><span style="font-size:14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:italic">新型双吖啶衍生物的合成、细胞毒性及其与</span><i><span lang="EN-US" style="font-size:14.0pt;
line-height:150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1">c-myc</span></i><span style="font-size:14.0pt;line-height:
150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;
mso-bidi-font-style:italic">启动子<span lang="EN-US">G-</span>四链体<span lang="EN-US">/i-motif</span>的相互作用研究）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal" style="line-height:150%"><b><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:italic">[</span></b><b><span style="font-size:14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:italic">摘要<span lang="EN-US">]</span>目的</span></b><span style="font-size:14.0pt;line-height:150%;
font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;
mso-bidi-font-style:italic"> 合成新的双吖啶衍生物<span lang="EN-US">A1-A4</span>，并研究其与</span><i><span lang="EN-US" style="font-size:14.0pt;
line-height:150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1">c-myc</span></i><span lang="EN-US" style="font-size:14.0pt;
line-height:150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-bidi-font-style:italic"> G-</span><span style="font-size:14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:italic">四链体<span lang="EN-US">/i-<a name="_Hlk157595514">motif</a> DNA</span>的相互作用和细胞毒性。<b>方法</b> 采用常规反应方法合成双吖啶衍生物<span lang="EN-US">A1-A4</span>。采用荧光共振能量转移（<span lang="EN-US">FRET</span>）熔点测定法、表面等离子体共振（<span lang="EN-US">SPR</span>）法、<span lang="EN-US">CD</span>实验和分子对接法研究了<span lang="EN-US">A1-A4</span>与</span><i><span lang="EN-US" style="font-size:14.0pt;
line-height:150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1">c-myc</span></i><span style="font-size:14.0pt;line-height:
150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;
mso-bidi-font-style:italic">启动子<span lang="EN-US">G-</span>四链体<span lang="EN-US">/i-</span></span><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:华文中宋;
color:black;mso-themecolor:text1"> </span><span lang="EN-US" style="font-size:
14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-bidi-font-style:italic">motif</span><span style="font-size:14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:italic">之间的相互作用。<span lang="EN-US">MTT</span>细胞毒性试验用于评价双吖啶衍生物<span lang="EN-US">A1-A4</span>对<span lang="EN-US">A375</span>、<span lang="EN-US">Hela</span>、<span lang="EN-US">A549</span>、<span lang="EN-US">U2OS</span>、<span lang="EN-US">HCT116</span>、<span lang="EN-US">Siha</span>、<span lang="EN-US">HuH7</span>等肿瘤细胞的细胞毒性。<b>结果</b><span lang="EN-US"> FRET</span>熔点测定法和<span lang="EN-US">SPR</span>测定结果表明，双吖啶衍生物<span lang="EN-US">A1-A4</span>能结合并稳定</span><i><span lang="EN-US" style="font-size:14.0pt;
line-height:150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1">c-myc</span></i><span lang="EN-US" style="font-size:14.0pt;
line-height:150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-bidi-font-style:italic"> G-</span><span style="font-size:14.0pt;line-height:150%;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:italic">四链体<span lang="EN-US">/i-motif</span>结构。<span lang="EN-US">CD</span>实验和分子对接结果证明了<span lang="EN-US">A1-A4</span>与</span><i><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1">c-myc</span></i><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:
italic"> G-</span><span style="font-size:14.0pt;line-height:150%;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:
italic">四链体<span lang="EN-US">/i-motif</span>之间的相互作用。<span lang="EN-US">MTT</span>实验表明，<span lang="EN-US">A1-A4</span>对人<span lang="EN-US">A375</span>、<span lang="EN-US">Hela</span>、<span lang="EN-US">A549</span>、<span lang="EN-US">U2OS</span>、<span lang="EN-US">HCT116</span>、<span lang="EN-US">Siha</span>、<span lang="EN-US">HuH7</span>肿瘤细胞的增殖具有较强的抑制作用。<b>结论</b> 双吖啶衍生物<span lang="EN-US">A1-A4</span>能与</span><i><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1">c-myc</span></i><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:
italic"> G-quadruplex/i-motif</span><span style="font-size:14.0pt;line-height:
150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;
mso-bidi-font-style:italic">结合并稳定，抑制人癌症细胞增殖，有望成为一类靶向</span><i><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1">c-myc</span></i><span lang="EN-US" style="font-size:14.0pt;line-height:150%;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-bidi-font-style:
italic"> G-quadruplex/i-motif</span><span style="font-size:14.0pt;line-height:
150%;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;
mso-bidi-font-style:italic">的小分子配体。<span lang="EN-US"> <o:p></o:p></span></span></p><p>



<b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:1.0pt;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA;mso-bidi-font-style:
italic">[</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:1.0pt;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA;mso-bidi-font-style:
italic">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:&quot;Times New Roman&quot;;
color:black;mso-themecolor:text1;mso-font-kerning:1.0pt;mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA"> </span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:1.0pt;mso-ansi-language:EN-US;mso-fareast-language:
ZH-CN;mso-bidi-language:AR-SA;mso-bidi-font-style:italic">合成；双吖啶衍生物；<span lang="EN-US">G-</span>四链体；<span lang="EN-US">i-motif</span>；细胞毒性</span><br></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:16:20 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4b22r263k1sxnrdyax77bez6m7</guid>
    </item>
    <item>
      <title>Research progress in the regulation of secondary metabolism in medicinal plants by MYB transcription factors</title>
      <link>https://jhip.gdpu.edu.cn/47zfpvw4nnep358jte3fwsaanj</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">Research
progress in the regulation of secondary metabolism in medicinal plants by MYB
transcription factors</span><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">（<span lang="EN-US">MYB</span>转录因子调控药用植物次生代谢的研究进展）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">摘要<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;color:black;mso-themecolor:
text1"> </span><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">MYB</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">转录因子是植物体内最大的转录因子家族之一，广泛参与植物生长发育的各个领域，在植物次生代谢产物的生物合成过程中发挥着重要的调节作用。目前关于<span lang="EN-US">MYB</span>转录因子的研究大多集中在农作物上，对药用植物的研究较少。因此，本研究综述了植物<span lang="EN-US">MYB</span>转录因子在药用植物次生代谢方面的研究进展，为更好地利用和开发药用植物提供了思路和方法。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoPlainText" style="line-height:28.0pt;mso-line-height-rule:exactly"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt"> MYB</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">转录因子；药用植物；次生代谢；研究进展<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:15:29 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/47zfpvw4nnep358jte3fwsaanj</guid>
    </item>
    <item>
      <title>Methodological project (SMART-PT) for transparency and methodological characteristics of randomized controlled trials of phytotherapy interventions</title>
      <link>https://jhip.gdpu.edu.cn/4kvfq2gby6rax71fcysnxt40c4</link>
      <description><![CDATA[<p class="MsoPlainText" style="line-height:28.0pt;mso-line-height-rule:exactly"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt">Methodological project
(SMART-PT) for transparency and methodological characteristics of randomized
controlled trials of phytotherapy interventions [</span><span style="font-size:
14.0pt;font-family:华文中宋;mso-bidi-font-family:宋体;color:black;mso-themecolor:
text1">植物疗法干预随机对照试验的透明度和方法学特征的方法学项目（<span lang="EN-US">SMART-PT</span>）</span><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt">]<o:p></o:p></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[</span></b><b><span style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">摘要<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt"> </span><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">背景与目的</span></b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt"> 随机对照试验（<span lang="EN-US">RCT</span>）被认为是评价医疗干预措施有效性和安全性的金标准。植物疗法在许多临床疾病的预防和治疗中发挥着关键作用，并通过<span lang="EN-US">RCT</span>进行评估。近年来，科学界广泛关注<span lang="EN-US">RCT</span>的透明度、方法学、普适性以及研究者的性别和地理位置差异。然而，植物疗法干预<span lang="EN-US">RCT</span>的这些方面尚未得到充分评价。因此，<span lang="EN-US">SMART-PT</span>项目（植物疗法干预随机对照试验的透明度和方法学特征）旨在填补这些知识空白，并为未来相关<span lang="EN-US">RCT</span>提供关键参考。<b>方法</b><span lang="EN-US"> SMART-PT</span>项目由<span lang="EN-US">5</span>项研究组成，该项目将基于来自两个高影响力植物疗法期刊（<span lang="EN-US">Phytomedicine</span>和<span lang="EN-US">Phytotherapy Research</span>）发表的<span lang="EN-US">RCT</span>完成。基于<span lang="EN-US">PubMed</span>数据库检索了相关<span lang="EN-US">RCT</span>研究，检索时限为建库至<span lang="EN-US">2023</span>年<span lang="EN-US">2</span>月<span lang="EN-US">13</span>日。目前已由两名研究人员独立完成了研究筛选，后续的数据提取和质量评价也将由两名研究人员独立进行。首先，我们将调查纳入<span lang="EN-US">RCT</span>的报告完整性，数据共享水平，以及是否存在“<span lang="EN-US">Spin</span>”现象（研究<span lang="EN-US">1</span>）。其次，我们将评估纳入<span lang="EN-US">RCT</span>的偏倚风险和二分类主要结局的统计脆性，同时似然比将用于重新解释统计学不显著的主要结局（研究<span lang="EN-US">2</span>）。第三，我们将评估纳入<span lang="EN-US">RCT</span>中植物疗法干预措施的报告完整性以及<span lang="EN-US">RCT</span>的可信度（研究<span lang="EN-US">3</span>）。第四，我们将调查纳入<span lang="EN-US">RCT</span>中社会人口学特征的报告情况和受试者的代表性（研究<span lang="EN-US">4</span>）。最后，我们将调查纳入<span lang="EN-US">RCT</span>摘要的报告完整性以及所列作者的性别和地理区域的代表性（研究<span lang="EN-US">5</span>）。<span lang="EN-US">R 4.2.3</span>、<span lang="EN-US">Stata 17/SE</span>和<span lang="EN-US">Excel
2019</span>将用于分析数据并创建图形。<b>结果与讨论</b><span lang="EN-US"> SMART-PT</span>项目纳入了<span lang="EN-US">152</span>项双臂、平行对照、优效性设计的<span lang="EN-US">RCT</span>研究。该项目所包括的<span lang="EN-US">5</span>项<span lang="EN-US">Meta</span>研究的结果最终将会提交给同行评审期刊进行发表。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[</span></b><b><span style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">关键词<span lang="EN-US">] </span></span></b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">植物疗法；透明度；可信度；统计显著性；性别；研究方案<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:14:29 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4kvfq2gby6rax71fcysnxt40c4</guid>
    </item>
    <item>
      <title>Vitamins strategies for psoriasis: An update on current scientific evidence</title>
      <link>https://jhip.gdpu.edu.cn/46h8dmtez7drbvpvc6ywq437ce</link>
      <description><![CDATA[<p class="MsoPlainText" style="line-height:28.0pt;mso-line-height-rule:exactly"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt">Vitamins strategies for
psoriasis: An update on current scientific evidence</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">（</span><span style="font-size:14.0pt;
font-family:华文中宋;mso-bidi-font-family:宋体;color:black;mso-themecolor:text1">维生素治疗银屑病：目前更新的科学证据</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">）</span><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:宋体;color:black;
mso-themecolor:text1"><o:p></o:p></span></b></p><p class="MsoPlainText" style="line-height:28.0pt;mso-line-height-rule:exactly"><a name="_Hlk156655974"><b><span lang="EN-US" style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[</span></b></a><b><span style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">摘要<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;color:black;mso-themecolor:
text1"> </span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
宋体;color:black;mso-themecolor:text1">银屑病是一种侵袭性慢性皮肤病，治疗方法包括局部、口服、偶尔皮下或静脉注射。然而，维生素替代银屑病一线疗法具有更多有意义的证据。脂溶性维生素和水溶性维生素补充剂作为二线治疗能减少系统用药可能产生的不良影响、增加患者依从性，并且治疗费用相对可负担。本文基于<span lang="EN-US">Pub Med</span>、<span lang="EN-US">Google Scholar</span>、<span lang="EN-US">Willy Library</span>等网站搜索的数据首次对脂溶性和水溶性维生素用于银屑病治疗进行比较研究。本文总结了基于脂溶性维生素（<span lang="EN-US">A</span>、<span lang="EN-US">D</span>、<span lang="EN-US">E</span>）和水溶性维生素（<span lang="EN-US">B<sub>2</sub></span>、<span lang="EN-US">B<sub>6</sub></span>、<span lang="EN-US">B<sub>12</sub></span>、<span lang="EN-US">C</span>）对银屑病的治疗效果，明确了口服补充维生素治疗银屑病和系统炎症的有效性。此外，本文还汇集了临床研究以及基于体外和体内的实验研究，这些研究结果同样表明维生素可以有效治疗银屑病。另外，本文还纳入了高效液相色谱法对脂溶性和水溶性维生素的化学鉴别。维生素疗法在银屑病治疗中的应用前景优良，为进一步提高其治疗效果开辟了新的视野。本文为了解治疗银屑病的维生素新兴疗法提供了参考。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoPlainText" style="line-height:28.0pt;mso-line-height-rule:exactly"><a name="_Hlk156655986"><b><span lang="EN-US" style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[</span></b></a><b><span style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:宋体;
color:black;mso-themecolor:text1"> </span><span style="font-size:14.0pt;
font-family:华文中宋;mso-bidi-font-family:宋体;color:black;mso-themecolor:text1">银屑病；维生素治疗；靶向机制；临床研究；色谱法分析</span><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt"><o:p></o:p></span></b></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:13:00 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/46h8dmtez7drbvpvc6ywq437ce</guid>
    </item>
    <item>
      <title>Chloroplast genome of Thesium chinense: The insight into phylogeny of Santalaceae</title>
      <link>https://jhip.gdpu.edu.cn/4kaptxqdxjwde1qt92cqrraaca</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">Chloroplast
genome of <i>Thesium chinense</i>: The insight into phylogeny of Santalaceae</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">（百蕊草叶绿体基因组对檀香科系统发育的认识）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[</span></b><b><span style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">摘要<span lang="EN-US">] </span></span></b><span style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">百蕊草是一种重要的常用中药。</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">本研究的目的是从百蕊草中获得更多的生物信息学，并对檀香科的系统发育进行更全面、深入的分析。本研究对百蕊草叶绿体基因组进行了测序，并对其关键基因进行了生物信息学分析，构建了檀香科系统发育树。中药的基因常影响代谢产物的生成和积累。百蕊草叶绿体基因组中的不同基因具有不同的生物学特性。檀香科及其相关科的系统发育系统与经典分类有显著差异。本研究为百蕊草的应用和鉴定奠定了坚实的基础。<b><span lang="EN-US"><o:p></o:p></span></b></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">[</span></b><b><span style="font-size: 14pt; font-family: 华文中宋; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">关键词<span lang="EN-US">] </span></span></b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">百蕊草；系统发育；叶绿体基因组；檀香科<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:11:48 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4kaptxqdxjwde1qt92cqrraaca</guid>
    </item>
    <item>
      <title>Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer</title>
      <link>https://jhip.gdpu.edu.cn/4dtngh566qhn21byyjyvgd75ck</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">Identifying
candidate drugs based on transcriptional landscape associated with
triple-negative breast cancer</span><span style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:
0pt">（基于三阴性乳腺癌特征转录谱的新药筛选研究）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">摘要<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;color:black;mso-themecolor:
text1"> </span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">三阴性乳腺癌（<span lang="EN-US">TNBC</span>）是<span lang="EN-US">ER</span>、<span lang="EN-US">PR</span>、<span lang="EN-US">HER2</span>均阴性的乳腺癌的一种特殊类型，具有恶性程度高、侵袭性强、复发率高等特点。开发新药对于改善三阴性乳腺癌的治疗至关重要。在本研究中，我们分析了三阴性乳腺癌相关的特征转录精细图谱，并在此基础上使用<span lang="EN-US">CMap</span>映射网络数据库筛选候选药物。结果表明候选药物可以激发转录组重编程，诱导<span lang="EN-US">TNBC</span>的反向特征表达谱，对三阴性乳腺癌患者的化疗耐药改善和生存率产生积极影响。同时，我们的研究还提供了一个结合计算机辅助虚拟筛选和进一步验证的药物开发新策略。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;color:black;mso-themecolor:text1;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;color:black;mso-themecolor:text1;mso-font-kerning:0pt">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1;mso-font-kerning:0pt"> </span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;color:black;
mso-themecolor:text1;mso-font-kerning:0pt">三阴性乳腺癌；映射网络；新药研发；特征转录谱</span><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
color:black;mso-themecolor:text1"><o:p></o:p></span></p>]]></description>
      <pubDate>Wed, 20 Mar 2024 08:09:56 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4dtngh566qhn21byyjyvgd75ck</guid>
    </item>
  </channel>
</rss>